Drug Trial Radar · NCT05062902
A Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain Management
Last checked: Nov 20, 2026Latest source record: Aug 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
46
Planned (sponsor's estimate)
Start
Sep 15, 2025
Primary completion
Aug 15, 2027
Study completion Dec 1, 2027
Sponsor
- Lead sponsor
- HillMed Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Baylor College of Medicine; University of Houston
- First posted
- Sep 30, 2021
Design
- Study type
- Interventional
- Phase
- Early phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate if it is possible to use intravaginal high-density surface electromyography to guide Botulinum neurotoxin (BoNT) injection to treat pelvic floor muscle overactivity that complicates Chronic Pelvic Pain (CPP).
Conditions
- Interstitial Cystitis
- Chronic Pain
- Pelvic Floor; Relaxation
- Pelvic Floor Disorders
Interventions
High Density Surface Electromyographic, precision botulinum neurotoxin injection guidance medical deviceDevice
A personalized, precision botulinum neurotoxin injection guidance medical device, utilizing an intra-vaginal high-density surface EMG system to optimize the treatment outcomes in chronic pelvic pain (CPP) management.
Botulinum NeurotoxinDrug
Botulinum neurotoxin will be injected into the pelvic floor muscles following either a standard template (standard injection arm), or guided using high-density surface EMG (guided arm).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Hypertonic metrics of the pelvic muscles defined by intra-vaginal surface EMGTime frame: Baseline
- Hypertonic metrics of the pelvic muscles defined by intra-vaginal surface EMGTime frame: 1-Month Post Injection
- Hypertonic metrics of the pelvic muscles defined by intra-vaginal surface EMGTime frame: 3-Months Post Injection
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Baylor College of Medicine
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.